Alle Bell- en Gongceremonies

Euronext’s key role in financing European companies

For Euronext, 2013 will be remembered as the year our markets returned to business as usual. Although the economic environment remains challenging in many European countries, Euronext’s markets played a major role in financing companies of all sizes in every sector. Companies raised €92 billion in 2013 on our markets, compared with €83 billion the previous year, including €29.4 billion in equity and quasi-equity and €62.3 billion in bonds. The largest operations included Numéricable’s that raised €750 million with its IPO in Paris, as well two other French operations: Alcatel Lucent’s €1 billion capital increase and EDF’s €1.4 billion bond issue. In Belgium, bpost raised €812 million with its IPO and in PortugaVEl, postal operator CTT raised nearly €580 million early December when it entered the market in Lisbon. In Amsterdam, we had the interesting OCI technical listing (listing and exchange offer of € 6.2 billion Market Cap).

Nearly forty new entries on the market were completed last year, including more than 20 IPOs which raised in excess of €3 billion, a level of financing that had not been achieved since 2007.

“These figures and operations testify the central role played by Euronext in the financing of the European economy. We work constantly to increase transparency, efficiency and security while monitoring our markets in order to attract investors to the exchange and support business growth,” said Marc Lefèvre, Director, Head of European Business Development & Client Coverage, Euronext. “It can be said that a positive sentiment and momentum is back on our Markets.”

There are several reasons for this successful development. Firstly, investors and individuals in the market have been reassured by rising indices following several years of recession. The CAC 40 rose 17.99% in 2013, the AEX 17.24%, the BEL 20 by 18.10% and the PSI 20 by 15.98%. At the same time, volatility has dropped to low levels, which is necessary for a dynamic market of new introductions on the exchange. The VSTOXX volatility index which had risen to almost 60% in 2009 dropped to 17% at the end of 2013, the same level as before the recession in 2007.

Among the reasons for the exchange’s return to centre stage is a dual redistribution between stocks and bonds in favour of the former on the one hand, and geographically between the United States and Europe with the latter in particular thriving. The valuations achieved also enable investment funds to sell some of their holdings via listings on the market.

After a very encouraging 2013, Euronext is expecting a confirmation of these trends in 2014.

New Listings

New listings during S2 2013 on Euronext

The CEOs comment their operations:

Hervé Montjotin CEO of Norbert Dentressangle: “We believe our listing on Euronext London will raise the profile of Norbert Dentressangle amongst the UK investment community who have a wealth of experience in the transport, logistics and supply chain sector.”

Pascal Gendrot, Co-founder and CEO of Orège: “Listing represents a major step ahead in our company's business development, and is clearly a springboard for structuring new strategic partnerships.”

Christian Homsy, CEO of Cardio3 BioSciences: “It is with great pride that we announce our listing in Brussels and in Paris. We are the first biotechnology company to list on both exchanges and welcome our new investors both institutional and private individuals.”

João Dantas, Executive Officer and Investor Relations Officer of BTG Pactual: “This transfer is a testimony to our continued cooperation with Euronext in Europe.”

Vincent Bolloré, Chairman of Blue Solutions: “After twenty years of hard work and R&D, our teams at Blue Solutions, with their unique expertise and know-how, are immensely proud to see their work listed on Euronext in Paris.”

Eric Denoyer, Chairman and CEO of Numericable Group: “Thanks to listing on Euronext and this capital increase we will be accelerating our investments over the next three years to strengthen our existing lead.”

Michel Giannuzzi, Head of Tarkett’s Management Board: “Today, Tarkett benefits from all of the strengths necessary to pursue its profitable, sustainable growth dynamic: a healthy, solid financial structure, a balanced geographical presence and a broad portfolio of solutions in the flooring and sports surface markets.”

Ludovic Lastennet, CEO of Implanet: “I am very happy with Implanet’s successful listing on Euronext where the number of health stocks has grown steadily and expanded its reach with international investors.”

Jacques Moulaert, Vice-president and Executive Director of Viohalco: “We strongly believe that Viohalco’s listing in Brussels today will boost its visibility and enhance its access to international capital markets.”

Bertin Nahum, Chairman & CEO and founder of Medtech: “I would like to thank all of the institutional and individual shareholders that have joined us, as well as all of our staff and partners, for their contributions to the success of our IPO.”

Koos Hendriks, CEO of SnowWorld: “The listing on Euronext Amsterdam is the basis of our ambition to realize the roll out of the SnowWorld concept in Europe.”

António Tomás Correia, Chairman of Montepio: “It is the first time that Montepio has equity capital listed on a stock exchange. It is a matter of great satisfaction for us and it establishes and strengthens our confidence in the future, taking into account the high number of subscribers - more than 25,000 - which shows the power of the brand”.

New listings during S2 2013 on Alternext

The CEOs comment their operation:

Hervé de Kergrohen, CEO of Medical Device Works: “Our technology - a unique approach designed to treat liver cancer more effectively by repeated isolation of the organ - has been developed with the support of our traditional shareholders and clinical partners. It will now benefit from the visibility offered by stock-exchange listing."

Alexandre Guichard, Chairman of RocTool: “Our transfer to Alternext and related capital increase have boosted RocTool’s credibility and will enable us to pursue a growth strategy focusing on international markets.”

Robert Lafont, Chairman and CEO of Entreprendre-Lafont Presse: “Our transfer to Alternext opens a new stage in our experience on the stock market. In today’s economy, it not only boosts our credibility, it also gives us the clout and support we need to face the new challenges in our sector.”

Jean-Claude Lumaret, Carbios CEO and founder: “Our successful listing gives us the resources we need to become a leading player in the world’s plastics and recycling markets.”

Jean-Claude Maillard, Chairman and CEO of Figeac Aéro: “The increased financial resources that result from this listing will allow us to step up the pace of growth and above all to deploy our strategy aimed at becoming a world leader in subcontracted services to the aerospace industry.”

The Euronext bond offer: tailor-made financing solutions for all companies

European companies raised €62.3 billion in bonds (including convertible bonds) on Euronext’s European markets in 2013. This success is evidence of investor appetite for corporate credit in an environment of historically low interest rates. It is also based on Euronext’s many innovative offers to support the transformation of traditional financing circuits, with Euronext’s bond offer segmented today to satisfy the needs of companies of all sizes, from the largest to the smallest.

“There are many advantages to a bond offer. Companies can diversify their financing sources and reduce their dependency on bank financing. No dilution for the shareholder, historically low rates, long maturity, no or few covenants... issuers have much to gain from turning to the bond market. At the same time, these offers also enable investors to benefit from all the advantages of a regulated or self regulated market: liquidity, transparency, security, efficiency and credibility”, says Marc Lefèvre, Director, Head of Business Development & Client Coverage Europe, Euronext.

Large companies thus have access to a broad range of solutions based on their desired criteria (investor, format, maturity, currency, etc.):

• Eurobonds. These enable the issuer to turn to European institutional investors via syndicated investment in the bond market. Companies must first obtain a credit rating. Euronext’s straightforward, long-term and transparent infrastructure has supported the strong growth of this product in recent years.
• Euro PP. Launched in 2012, euro private placement bonds (Euro PP) allow mid-cap companies to to issue bonds with qualified institutional investors, in particular insurers. Private placement benefits from a specific legal framework and a format tailored to the companies concerned. This long awaited investor tool is also an efficient response to banking disintermediation.
• Retail bond offer. This allows a company to access the institutional and individual investor markets to expand its financing possibilities and increase its visibility with a loyal target group. Ratings are not required for large companies.

SMEs have access to Euro PPs and retail investors (Initial Bond Offering – IBO); this latter offer, launched in 2012, allows listed and non listed companies to turn to institutional and individual investors via a public offer on the regulated (Euronext) or self regulated (Alternext) market using a centralization process similar to that involved in an IPO. Ratings are required for listed SMEs with market capitalization of less than €100 million, and for non-listed companies¹.

“Demand from institutional and individual investors is strong for these quality bond products that offer attractive returns and meet today’s prudential standards. Euronext’s expansive bond offer is part of our major effort to redirect investor savings towards productive investment,” says François Houssin, Head of Client Coverage France for Euronext.

¹ For non-listed companies which follow the criteria of the European SME definition.

Lisbon Newsbites

IPOs are back in force in Lisbon

IPO activity was intense in Lisbon in 2013.  Nexponor “opened the market” in June with an Alternext listing by raising €65 million in new equity. However, it was December that tipped the scales with two IPOs and one technical listing:

• 5 December: CTT Correios de Portugal listed on Euronext after the government sold a 70% stake: 14% to retail and 56% to institutional investors. Over 25,000 investors bought CTT shares in what was the largest IPO in Portugal since 2008.

  

• 12 December: German-based HQ Life listed on Easynext Equities. This private equity company was the first to list on this market since 1999. 
  
• 17 December: Caixa Económica Montepio Geral raised €200 million in participation units. Roughly 25,000 retail investors, all Montepio clients, subscribed to these innovative equity instruments. 

Contacts

Miguel Geraldes (Head of Listings, Euronext)
+351/21 790 0062
mgeraldes@euronext.com

Pedro Wilton (Senior Account Manager, Euronext)
+351/21 790-0102
pwilton@euronext.com

ExpertLine: +351/21 790-0055
For more information or for specific questions, please contact your Account Manager or send an email to MyQuestion@euronext.com. 
 

Paris Newsbites

A new SME stock savings account to boost the small- and mid-cap segment

A boost for small and medium-sized companies: this is the goal for the new SME stock saving accounts (PEA PME) that will be launched  in France at the beginning of this year. Benefiting from the same tax advantages as traditional stock saving accounts (PEA), this new form of saving accounts must have 75% of securities being SMEs, half in stock, without exceeding €75,000. Eligible companies will be those with fewer than 5,000 employees and a turnover of less than €1.5 billion, or total assets inferior to €2 billion. Professionals estimate that this new product will be able to attract one to two billion euros – a most welcomed addition of financing for small and medium-sized companies that sometimes might struggle to get enough support.

Asset managers show strong interest for these new saving accounts. “This innovation expands the investment radar in favour of small and medium-sized companies,” says Diane Bruno, manager at Mandarine Gestion. “By offering a new opportunity for tax savings, the PEA PME could interest people whose existing stock account has capped out.” Investing in PEA PME would not lead to sacrifice any performance. “Small and mid-caps have been outperforming structurally since 2000”, notes Diane Bruno. A large majority of management companies are therefore expected to create funds that qualify for this new PEA.

To assist the Management companies, Euronext is preparing to launch a PEA PME index developed together with Société Générale. “We very much want to support the small and mid-cap compartment. Our initiative will supplement and buttress EnterNext’s efforts in this area”, says George Patterson, Euronext index manager. “Creating a benchmark will support this listing segment, as well as respond to a demand from professionals.” This index, initially limited to France and containing around forty securities, will meet PEA PME eligibility criteria as well as its liquidity criteria, with a required minimum of €250,000 in daily transactions. Further on, a pan-European index is in the pipeline.

Renewed strength of the Parisian markets in 2013

Euronext Paris played a major role in financing the French economy in 2013. Companies listed on our markets raised €64.3 billion last year, including €10.5 billion in equity and €53.7 billion in bonds. Moreover, unlisted companies also benefited from Euronext’s dynamism and listed numerous bond issues on our markets.

A total of 26 companies entered Euronext or Alternext Paris, compared with 19 in 2012 (+37%), representing an additional market capitalization of €80 billion, with €72bn coming from cross-Atlantic dual listings of Infosys and Eli Lilly. Around 20 of these operations were accompanied by public offers raising a total of €1.3 billion (a growth rate of more than 400% compared to 2012). One of these issuers was Cardio 3 Biosciences that became the first company to successfully list and raise money in Paris and Brussels simultaneously.

The three largest primary capital raisings on Euronext were Numéricable (€750 million), Tarkett (€462 million) and Blue Solutions (€42 million), all three taking place in the fourth quarter. On Alternext, the largest operations were Figeac Aero (€18 million), Carbios (€13 million) and Spineguard (€8 million) and Spineway (€5 million).

Contacts

Joseph Brigneaud (Business Development and Client Coverage Manager Rhône–Alpes & Auvergne regions, EnterNext)
Tel. +33 (0)4 72 40 56 97
jbrigneaud@euronext.com

Jean-Baptiste Celard (Business Development and Client Coverage Manager West and East regions, EnterNext)
Tel. +33 (0)1 49 27 50 38
jbcelard@euronext.com

Nicolas-Gaston Ellie (Business Development and Client Coverage Manager South-West region, EnterNext)
Tel. +33 (0)1 49 27 11 22
ngellie@euronext.com

Eric Forest (Chairman and CEO, EnterNext)
Tel. +33 (0)1 49 27 10 78
eforest@euronext.com

François Houssin (Head of Client Coverage France, Euronext)
Tel. +33 (0)1 49 27 12 65
fhoussin@euronext.com

Stéphane Laskart (Business Development and Client Coverage Manager West and East regions, EnterNext)
Tel. +33 (0)1 49 27 10 31
slaskart@euronext.com

Marc Lefèvre (Head of European Listings Clients & Business Development, Euronext)
Tel. +33 (0)1 49 27 10 87
mlefevre@euronext.com

Guillaume Mordelet (Business Development and Client Coverage Manager Mediterranean Area, EnterNext)
Tel. +33 (0)4 91 13 46 46
gmordelet@euronext.com

Guillaume Morelli (Business Development and Client Coverage Manager SMEs, Ile de France and North regions, EnterNext)
Tel. +33 (0)1 49 27 12 98
gmorelli@euronext.com

ExpertLine:

Tel. + 33 (0)1 49 27 15 15

For more information or for specific questions, please contact your Account Manager or send an email to MyQuestion@euronext.com.

Brussels Newsbites

First European Advanced Therapies Biotech Investor Day

Euronext hosted and co-organised together with the Alliance for Advanced Therapies the first European Advanced Therapies Biotech Investor Day on 29 November 2013. Leaders of European advanced therapies companies met with investors, brokers, analysts and journalists to showcase the potential of new cell-, tissue-, and gene-based therapies and discuss investment strategies. Eduardo Bravo, Chair of the Alliance for Advanced Therapies, opened the European stock markets in Brussels with a bell ceremony commemorating the first meeting of its kind in Europe.

“Three European companies from the advanced therapies sector have gone public since the beginning of 2013, two of which on Euronext markets: Erytech Pharma (France) and Cardio3 BioSciences (Belgium). We anticipate that many more will follow in the coming years,” declared Vincent Van Dessel, Chairman and Chief Executive Officer of Euronext Brussels.  

Belgian Investor Day in Zurich

Euronext hosted the first Belgian Investor Day in Zurich on 4 December 2013 in partnership with Bank Degroof. More than 80 one-to-one meetings were organised between Swiss professional investors and the 14 Belgian listed companies during this day of networking and conferences. Damien Petit, Bank Degroof Senior Economist, provided some perspective on the topic: “The Euro area, light at the end of the tunnel?”

Viohalco: the largest EnterNext listing in 2013

Viohalco, the holding company for a large metals group, celebrated its listing in Brussels on 22 November 2013. The reference price of Viohalco shares was €4.19 per share, valuing the company at €920 million at the listing date. “We are delighted with Viohalco's listing on Euronext Brussels and congratulate the company upon joining a community of over 160 other international issuers listed on our European markets.” said Alain Baetens, Head of Listings of Euronext.

Contacts
Alain Baetens (Head of Listings Belgium, NYSE Euronext),
+32/2 509-1279
abaetens@euronext.com

ExpertLine: +32/2 509-9595
For more information or for specific questions, please contact Alain Baetens or send an email to MyQuestion@euronext.com.

Amsterdam Newsbites

Unveiling of the “Amsterdam Exchange Experience” in the presence of her majesty Queen Maxima

Euronext presents the “Amsterdam Exchange Experience”, a new interactive and permanent exhibition about the role of the exchange in the local economy, developed with a view to financial education. On 6 November 2013, the exposition was opened during the centennial celebration of the Amsterdam exchange building in the presence of Her Majesty Queen Máxima. The Queen took part in a festive dinner with key clients and stakeholders where she spoke in her capacity as a member of the Committee for Enterprise and Finance and honorary chair of the Money Wise Platform. The Amsterdam Exchange Experience was opened to the public on 11 November.

Cees Vermaas, CEO of Euronext Amsterdam: “We are very proud of the opening of the Amsterdam Exchange Experience. The purpose is to make people aware of the importance of the exchange and its listed companies for the Dutch economy. In the Experience we explain the functioning of the capital market in an understandable manner”.

Those interested can register for the tours of the Experience on the website www.amsterdam-exchange-experience.com.

EnterNext welcomes SnowWorld 

EnterNext, the Euronext subsidiary dedicated to promoting and supporting SMEs, welcomed the listing of SnowWorld on 12 December 2013. SnowWorld manages two indoor ski facilities and is one of the world’s leading companies in this industry. The company has grown rapidly since its foundation in 1996.

Cees Vermaas, CEO of Euronext Amsterdam declared: “SnowWorld is a good example of successful Dutch entrepreneurship. With the listing on Euronext Amsterdam a new phase will start for the company in which they can benefit from the exchange as a partner and alternative financing source.”

Koos Hendriks, CEO of SnowWorld said: “The listing on Euronext Amsterdam is the basis of our ambition to realize the roll out of the SnowWorld concept in Europe.”

Contacts

Hans Leufkens (Head of Business Development SMEs Netherlands, EnterNext),
+31/20 550-4687
hleufkens@euronext.com

Anne-Louise van Lynden (Head of Listings Netherlands, Euronext),
+31/20 550-4107
alvanlynden@euronext.com

ExpertLine: + 32/20 550-4545

For more information or for specific questions, please contact your Account Manager or send an email to MyQuestion@euronext.com
 

Stichting Opkikker luidt gong voor nieuwe campagne

Om de 8-jarige Jay-jay Willems de dag van zijn leven te geven liet Stichting Opkikker in samenwerking met de Ajax Foundation zijn grote droom uitkomen: spelen bij Ajax.

Behalve een vrolijke jongen van acht en Ajacied in hart en nieren is Jay-jay ook langdurig ziek. Via een sonde in zijn buik bijna moet hij een liter medicijnen per dag tot zich nemen. De ziekte heeft een enorme impact op het dagelijkse leven van Jay-jay en zijn familie. Jay-jay werd door het Emma Kinderziekenhuis aangemeld bij Stichting Opkikker.

Opkikker verzorgt speciale Opkikkerdagen voor gezinnen met een langdurig ziek kind. Jay-jay is het gezicht van de nieuwe campagne van Stichting Opkikker, waarin de stichting aandacht vraagt voor de noodzaak om dagen ontspanning te blijven organiseren voor gezinnen met een ziek kind. De unieke beelden van Jay-jay’s Opkikkerdag zijn inmiddels al meer dan een miljoen keer bekeken. De gehele campagne werd kosteloos ontwikkeld.

Meer informatie vindt u op: www.opkikker.nl

Download foto

Espírito Santo Saúde rings the closing Bell

Espírito Santo Saúde CEO, Isabel Vaz, along with the board of the company, rang the closing bell in Lisbon to celebrate the Initial Public Offering (IPO) and the capital increase. With this operation, the ESS raised funds of approximately EUR 150 million, which will be used to finance its current activity and future investments.

Winnaars beleggingscompetitie Scholenstrijd luiden gong

Leerlingen van Het Olympus College uit Arnhem luiden de gong als winnaars van de beleggingscompetitie Scholenstrijd. Het Olympus College won zowel de prijs voor het beste rendement als de prijs voor het beste risico/rendement.

Scholenstrijd is een beleggingscompetitie voor leerlingen en docenten economie in de bovenbouw van HAVO en VWO. Voor Scholenstrijd worden leerlingen in groepjes van drie of vier ingedeeld. Elk groepje kruipt in de rol van beleggingsadviseur en moet een beleggingsadvies opstellen voor bijvoorbeeld vader, moeder of grootouder. De scholieren krijgen een virtueel startkapitaal van 100.000 euro waarmee zij kunnen beleggen in aandelen en beleggingsfondsen met een notering aan Euronext Amsterdam.

Meer informatie vindt u op: www.scholenstrijd.nl

Download foto

DSM viert 25 jaar beursnotering

Met een slag op de gong viert DSM 25 jaar beursnotering aan de Amsterdamse beurs. De notering vond plaats op 6 februari, 1989.

DSM was destijds een petrochemisch bedrijf en voornamelijk actief in Nederland. Nu, 25 jaar later, is DSM een Life Sciences en Materials Sciences-onderneming met meer dan 200 locaties wereldwijd en activiteiten op vijf continenten. In 25 jaar tijd is de prijs van het aandeel van DSM met meer dan 500% gestegen. DSM wordt vertegenwoordigd te Beursplein 5 door een groep jonge managers, actief in verschillende functies zoals Mergers & Acquisitions, Business Control, Operational Audit, Tax, Treasury, Productie, Investor Relations en Communicatie. Investor Relations Manager van DSM, Marc Silvertand, luidt de gong.

Meer informatie vindt u op: www.dsm.com

Download foto

Bell Ceremony om de notering van de obligaties door Hamon te vieren

Op 5 februari 2014 heeft Francis Lambilliotte, CEO van Hamon and Christophe Maréchal, Group Treasurer van Hamon, de Europese markten geopend met een Bell Ceremony om de eerste notering te vieren van een obligatielening van 55 miljoen Euro op Euronext Brussels. Deze obligatie heeft een looptijd van 6 jaar en een couponrente van 5.5%.  KBC Bank en BNP Paribas Fortis, waren de Joint Lead Managers.

De Hamon groep is een wereldspeler op het gebied van engineering en contracting.

Wenst u meer te weten omtrent Hamon, klik dan op volgende link : www.hamon.com

20 jarig Wereld Kanker Onderzoek Fonds luidt gong voor Wereld Kanker Dag 2014

Kanker is inmiddels wereldwijd de belangrijkste doodsoorzaak met ruim 8,2 miljoen sterfgevallen per jaar. Wereld Kanker Dag 2014, die dit jaar plaatsvond op dinsdag 4 februari, stond in het teken van ‘Fabels en feiten over kanker’. De hele wereld staat dan stil bij het feit dat kanker het grootste gezondheidsprobleem is waar we in onze generatie mee geconfronteerd worden. Het Wereld Kanker Onderzoek Fonds vraagt daarom met een slag op de gong extra aandacht voor het belang en de noodzaak van preventie.

Het Wereld Kanker Onderzoek Fonds viert dit jaar haar 20 jarig jubileum als autoriteit op het gebied van kankerpreventie door middel van gezonde voeding en leefstijl in Nederland. De stichting maakt deel uit van het wereldwijde World Cancer Research Fund (WCRF) netwerk, een netwerk van onafhankelijke stichtingen wereldwijd die zich inzetten voor de preventie van kanker. Uit wetenschappelijk onderzoek van het Wereld Kanker Onderzoek Fonds blijkt dat ruim een derde van de meest voorkomende gevallen van kanker voorkomen kan worden door gezond te eten, meer te bewegen en een gezond gewicht te behouden. Directeur van het Wereld Kanker Onderzoek Fonds, Nadia Ameyah, luidt de gong.

Meer informatie vindt u op: www.wcrf.nl

Download foto

DEGIRO vraagt aandacht voor hefboomcampagne

DEGIRO, een online broker en beleggingsplatform, vraagt met een slag op de gong aandacht voor de lancering van de hefboomcampagne. De campagne is gericht op ervaren en actieve beleggers. Zij kunnen vanaf dit moment een half jaar lang tegen € 0,- transactiekosten bij DEGIRO beleggen in hefboomproducten van ABN AMRO, ING, RBS, Citi en Commerzbank.

Op het gebied van hefboomproducten zoals Turbo’s, Sprinters en Speeders bereikt DEGIRO extra efficiëntie door op IT gebied nauw samen te werken met de uitgevende instellingen. Gijs Nagel, directeur retail, luidt de gong.

Meer informatie vindt u op: www.degiro.nl

Download foto

Gongslag markeert Amsterdam City Index

De gongslag markeert de Amsterdam City Index 2014 die in 2014 op 118 staat.

De index is een uitgave van bedrijvenvereniging Amsterdam City en meet middels 33 trends het economisch klimaat van de Amsterdamse binnenstad Centrum XL – het uitgebreide centrum van Centraal Station tot Cornelis Schuytstraat en van de Haarlemmerbuurt tot Carré. In één cijfer en vele toelichtingen vertelt de index de actuele stand van de economie in de Amsterdamse binnenstad. Vorig jaar eindigde de index op 117. Voorzitter van Amsterdam City, Willem Koster, luidt hiervoor de gong.

Meer informatie vindt u op: www.amsterdamcityindex.nl

Download foto

Gongslag markeert inschrijving Philips Innovation Award

De Philips Innovation Award (PHIA) wordt dit jaar voor de negende keer voor en door studenten georganiseerd. Inmiddels is de PHIA gegroeid tot de grootste studenten-ondernemerschapsprijs van Nederland. Jaarlijks helpt de organisatie studenten met een innovatieve geest van idee naar business plan en van business plan naar start-up.

De PHIA nodigt studenten uit om voor 16 februari 2014 een businessplan in te leveren om deel te nemen aan de competitie. De businessplannen ontvangen feedback van een jury die bestaat uit ervaren mensen uit het zakenleven. De tien beste plannen ontvangen coaching van partners van de organisatie en nemen deel aan de halve finale op 27 maart. De vijf beste teams strijden op 24 april voor de hoofdprijs.

Om studenten te helpen met het schrijven van een businessplan, heeft de organisatie voor het eerst in haar geschiedenis een online lecture traject ontwikkeld. In vier lectures worden door experts o.a. intellectueel eigendom, marketing en de financiering van startende ondernemingen belicht. Via de website van de organisatie kunnen de lectures worden bekeken op computer, tablet en/of smartphone. De interactieve opzet van dit traject maakt het mogelijk vragen te stellen aan de gastdocenten. Daan van Maanen, Senior Director M&A Philips, luidt de gong.

Meer informatie vindt u op: www.phia.nl

Download foto

Bell Ceremony om de eerste notering van de opties op RTL te vieren

Op 29 januari 2014 heeft Guillaume de Posch, CEO van RTL Group, de markten geopend met een Bell Ceremony om de eerste notering te vieren van de opties op het aandeel RTL op de derivatenmarkt van Euronext Brussel. Elmar Heggen, CFO van RTL Group en Philippe Delussine, CEO van RTL Belgique waren eveneens vertegenwoordigd op het podium van de Bell Ceremony. Het tradingsymbool van deze nieuwe optie is : RTL.

Via de introductie van opties op het aandeel RTL Group breidt Euronext de beleggingsopportuniteiten  voor investeerders verder uit en bouwt verder aan de ontwikkeling van de Belgische optiemarkt.

RTL Group is het toonaangevende  entertainmentnetwerk in Europa met belangen in 55 televisiezenders en 27 radiostations en met contentproductie  in de hele wereld.

Om meer te weten te komen over RTL : www.rtlgroup.com of www.rtl.be

Contract specificaties : https://www.euronext.com/en/for-investors/financial-derivatives

Hartstichting viert 50-jarig bestaan met slag op gong

Op 29 januari viert De Hartstichting haar 50-jarig bestaan met een slag op de bekende beursgong.

De feestelijke aftrap van het jubileumjaar wordt gedaan door de directeur van de Hartstichting, Floris Italianer in aanwezigheid van mevrouw Ruigrok. Mevrouw Ruigrok heeft aan den lijve ondervonden wat het belang is van reanimeren. Zij is zelf namelijk succesvol gereanimeerd door haar partner en kan gelukkig haar verhaal nog navertellen. Helaas is dat niet vanzelfsprekend. Dit jaar zet de Hartstichting dan ook groot in om van Nederland een 6-minuten zone te maken. Deze zone is een gebied waar het mogelijk is om binnen 6-minuten alle handelingen uit te voeren die nodig zijn bij een hartstilstand: 112 bellen, reanimeren en defibrilleren. Met de 6-minuten zone wil de Hartstichting de overlevingskans vergroten naar 25%.

Een aantal beursgenoteerde bedrijven heeft de Hartstichting hun steun toegezegd om zich in te zetten voor een 6-minuten zone en een hartgezonde samenleving. De Hartstichting dankt Aegon, Corio, DSM, Fugro, Imtech, Philips, PostNL, Unilever, Ziggo en Wolters Kluwer voor hun steun.

Meer informatie vindt u op: www.hartstichting.nl

Download foto